UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Digital Pathology

Game Winning Hits: Singles or Home Runs?

To use a baseball analogy – there have been more games won with singles than with home runs. Home runs, when they happen, are spectacular, but they are few and far between. The journeyman single, while not the stuff of legend, gets the job done, and happens frequently. When it comes to the practical application of artificial intelligence in digital pathology, the analogy holds. The home run is machine diagnosis – replacement of the pathologist – the holy grail. The single represents baby steps which improve pathology practice, right up until the technology reaches its inevitable maturity.

Read More

Image Based Risk Assessment in Cancer

Pathologists identify and interpret the changes that characterise diseases in cells and tissues, both for the studying/understanding disease processes in general and obtaining clinically relevant information for individual patients. Historically, by examining biopsy specimens, pathologists identified whether a lesion was neoplastic, inflammatory, or some other broad category. As medicine evolved, the task evolved into identifying more specific classifications. For example, if it was not sufficient to make the diagnosis of cancer; it was necessary to identify the specific subtype and grade of cancer in order to inform treatment decisions that were becoming increasingly sophisticated.

Read More

The Optimization of Digital Pathology Technology: An Open Letter from Yukako Yagi

Dear Colleagues,

As the field of digital pathology continues to evolve, we are discovering new and exciting ways to use and apply the technology. Digital Pathology is entering a new era, revealing an unprecedented breadth and depth of information for cancer research and diagnosis. Whole slide imaging (WSI) will take an important role in the development of future technologies, imaging modalities and systems, and impact clinical workflows, yielding a comprehensive multi-dimensional analysis that would otherwise be impossible!

Read More

Effective Implementation & Utilisation of Diagnostic Technology in the NHS

An inquiry by the House of Lords’ Science & Technology Committee has identified several issues that could hamper the delivery of the Life Sciences Industrial Strategy vision1. The critical report (Life Sciences Industrial Strategy: Who’s driving the bus? 1) brings together evidence from industry, academia and the NHS. It highlights several implementation challenges which require “prompt and vigorous action by the government” to ensure that the scope of Life Sciences Industrial Strategy can be achieved.

Read More

New Digital Pathology Strategies & Re-Imagined Diagnostic Services in the UK

An evaluation of the UK’s pathology capacity by Cancer Research UK (CRUK) has identified that over the next 5-10 years “there is likely to be a severe crisis.” The report highlights a 4.5% year-on-year increase in the number and complexity of histopathology requests since 2007/08; the majority of which are for the investigation of cancer.

Read More

Software and Systems for Digital Pathology

Presented at the 4th Digital Pathology Congress, these 3 sets of slides on software and systems for digital pathology are available. Feel free to download and share with your colleagues.

Read More

Jo Martin on Women in Science

At the 4th Digital Pathology Congress in London, we caught up with the president of the Royal College of Pathologists, Jo Martin. She gave us an insight into her career and advice for women getting into science.

Read More

Will Digital Pathology Replace Pathologists?

Bethany Williams was the world’s first Leadership and Management Fellow in Digital Pathology and is now a PhD Fellow at Leeds Teaching Hospital NHS Trust and the University of Leeds. We caught up with her at the 4th Digital Pathology Congress where she spoke to us about the future of digital pathology and reflected on her greatest career achievements.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive